$GOVX
GeoVax Labs, Inc. Stock $govx

$govx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000143774922018639 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$81.53K
YoY Change	-100.0%	-100.0%	-26.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.249M	$935.3K	$1.179M
YoY Change	64.94%	27.51%	10.19%
% of Gross Profit
Research & Development	$2.721M	$1.307M	$1.331M
YoY Change	122.25%	56.96%	120.73%
% of Gross Profit
Depreciation & Amortization	$17.67K	$12.27K	$12.27K
YoY Change	97.65%	-31.34%	171.62%
% of Gross Profit
Operating Expenses	$3.971M	$2.242M	$2.510M
YoY Change	100.35%	43.17%	49.87%
Operating Profit	-$3.971M	-$2.242M	-$2.428M
YoY Change	103.47%	50.84%	55.24%
Interest Expense	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$2.431K	$789.00	$527.00
YoY Change	177.19%	-99.54%	-59.4%
Pretax Income	-$3.968M	-$2.242M	-$2.428M
YoY Change	103.44%	70.6%	55.61%
Income Tax
% Of Pretax Income
Net Earnings	-$3.968M	-$2.242M	-$2.428M
YoY Change	103.44%	70.6%	55.33%
Net Earnings / Revenue			-2977.6%
Basic Earnings Per Share	-$0.17	-$0.18	-$0.34
Diluted Earnings Per Share	-$169.1K	-$176.2K	-$341.4K
COMMON SHARES
Basic Shares Outstanding	24.74M	12.72M	7.109M
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.68M	$30.90M	$16.26M
YoY Change	91.51%	58.16%	-21.99%
Cash & Equivalents	$34.68M	$30.90M	$16.26M
Short-Term Investments
Other Short-Term Assets	$1.460M	$1.136M	$279.7K
YoY Change	2664.5%	862.2%	133.04%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00	$99.53K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$36.14M	$32.04M	$16.64M
YoY Change	99.0%	62.99%	-20.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$249.0K	$214.8K	$206.9K
YoY Change	47.63%	43.38%	44.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.184M	$987.5K	$11.01K
YoY Change	19739.11%	8869.19%	10.1%
Total Long-Term Assets	$2.433M	$1.202M	$217.9K
YoY Change	1254.35%	647.65%	41.26%
TOTAL ASSETS
Total Short-Term Assets	$36.14M	$32.04M	$16.64M
Total Long-Term Assets	$2.433M	$1.202M	$217.9K
Total Assets	$38.57M	$33.24M	$16.85M
YoY Change	110.31%	67.73%	-20.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.079M	$237.3K	$426.1K
YoY Change	272.94%	-18.08%	83.28%
Accrued Expenses	$3.710M	$3.131M	$3.075M
YoY Change	7928.18%	4414.66%	8296.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.789M	$3.368M	$3.501M
YoY Change	1326.9%	838.07%	674.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$2.000M	$2.000M	$2.000M
YoY Change
Total Long-Term Liabilities	$2.000M	$2.000M	$2.000M
YoY Change			19900.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.789M	$3.368M	$3.501M
Total Long-Term Liabilities	$2.000M	$2.000M	$2.000M
Total Liabilities	$6.789M	$5.368M	$5.501M
YoY Change	1922.76%	1395.14%	1085.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.01M	-$69.05M	-$66.80M
YoY Change	44.2%	41.83%	41.03%
Common Stock	$104.8M	$96.92M	$78.16M
YoY Change	52.68%	42.23%	15.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.78M	$27.87M	$11.35M
YoY Change
Total Liabilities & Shareholders Equity	$38.57M	$33.24M	$16.85M
YoY Change	110.31%	67.73%	-20.18%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.968M	-$2.242M	-$2.428M
YoY Change	103.44%	70.6%	55.33%
Depreciation, Depletion And Amortization	$17.67K	$12.27K	$12.27K
YoY Change	97.65%	-31.34%	171.62%
Cash From Operating Activities	-$3.799M	-$3.834M	-$4.333M
YoY Change	132.55%	204.36%	167.31%
INVESTING ACTIVITIES
Capital Expenditures	-$51.88K	-$20.19K	$62.19K
YoY Change	86.69%	1.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$51.88K	-$20.19K	-$62.19K
YoY Change	86.69%	1.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.626M	18.50M	$9.229M
YoY Change	3215.45%	-71827.49%	-26.64%
NET CHANGE
Cash From Operating Activities	-3.799M	-3.834M	-$4.333M
Cash From Investing Activities	-51.88K	-20.19K	-$62.19K
Cash From Financing Activities	7.626M	18.50M	$9.229M
Net Change In Cash	3.775M	14.64M	$4.834M
YoY Change	-363.68%	-1221.95%	-55.89%
FREE CASH FLOW
Cash From Operating Activities	-$3.799M	-$3.834M	-$4.333M
Capital Expenditures	-$51.88K	-$20.19K	$62.19K
Free Cash Flow	-$3.747M	-$3.813M	-$4.395M
YoY Change	133.34%	207.62%	171.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11423870	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16238739
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16238739
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6381541
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6381541
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	2000000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39563
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0455038
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Lake Park Drive, Suite 380
	dei	Entity Address City Or Town EntityAddressCityOrTown	Smyrna
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30080
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1135780	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	156240	usd
CY2021Q4	us-gaap	Grants Receivable GrantsReceivable	49006	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1135780	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	156240	usd
CY2021Q4	us-gaap	Assets Assets	11797064	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	832835	usd
	dei	City Area Code CityAreaCode	678
	dei	Local Phone Number LocalPhoneNumber	384-7220
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2637721	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1435618	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	237315	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2057534	usd
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3130553	usd
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1307177	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24744043
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30902454	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	-0	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	32038234	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	11629116	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	214783	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156938	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	987508	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11010	usd
CY2022Q2	us-gaap	Assets Assets	33240525	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3377826	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3367868	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5435360	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2000000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5367868	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7435360	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	16239	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	6382	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96901530	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	68731220	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69045112	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64375898	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27872657	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4361704	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33240525	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11797064	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	79708	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81526	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	190125	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	935311	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	733499	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2114335	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1805209	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2242488	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1566334	usd
	us-gaap	Operating Expenses OperatingExpenses	4752056	usd
	us-gaap	Operating Expenses OperatingExpenses	3240827	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2242488	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1486626	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4670530	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3050702	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	789	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1068	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1316	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3121	usd
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2021Q2	us-gaap	Interest Expense InterestExpense	531	usd
	us-gaap	Interest Expense InterestExpense	-0	usd
	us-gaap	Interest Expense InterestExpense	1286	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	172056	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	0	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2067492	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	172056	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	789	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	172593	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1316	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	173891	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2241699	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1314033	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4669214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2876811	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12721696
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6322799
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9931088
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5830165
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4361704	usd
CY2022Q1	govx	Stock And Warrants Issued During Period Value Common Stock And Warrants StockAndWarrantsIssuedDuringPeriodValueCommonStockAndWarrants	9229248	usd
CY2022Q1	govx	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	24	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	190191	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2427515	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11353652	usd
CY2022Q2	govx	Stock And Warrants Issued During Period Shares Common Stock And Warrants StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants	18497946
CY2022Q2	govx	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	567	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	190191	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2241699	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27872657	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9568852	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9408920	usd
CY2021Q1	govx	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	3174156	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	6000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56190	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1562778	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	20651340	usd
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	65841	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56190	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1314033	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	19458338	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4669214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2876811	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24538	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17871	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	412329	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	163553	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	172056	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-49006	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-182663	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	939487	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-71319	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-976498	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	27864	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27727785	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-266105	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-3497604	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-2755	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8166818	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2879566	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	82383	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	13045	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	60000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19929	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-82383	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19929	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27727194	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9408920	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	591	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3174156	usd
	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	-0	usd
	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	1000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12554212	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19478584	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9654717	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11423870	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9883796	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30902454	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19538513	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em></b> <b>Nature of Business </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">GeoVax Labs, Inc., headquartered in the Atlanta, Georgia metropolitan area, is a clinical-stage biotechnology company incorporated under the laws of the State of Delaware. GeoVax Labs, Inc. and its wholly owned subsidiary, GeoVax, Inc., a Georgia corporation, are collectively referred to as “GeoVax” or the “Company”.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company is focused on developing immunotherapies and vaccines against infectious diseases and cancers using novel vector vaccine platforms. GeoVax’s product pipeline includes ongoing human clinical trials in COVID-<em style="font: inherit;">19</em> and head and neck cancer. Additional research and development programs include preventive vaccines against Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa) and malaria, as well as immunotherapies for solid tumors.</p>
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	108826	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3130553	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3377826	usd
CY2022Q2	govx	Prepaid Clinical Trial Expenses Current PrepaidClinicalTrialExpensesCurrent	1020352	usd
CY2021Q4	govx	Prepaid Clinical Trial Expenses Current PrepaidClinicalTrialExpensesCurrent	0	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	42383	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	123248	usd
CY2022Q2	us-gaap	Prepaid Rent PrepaidRent	13045	usd
CY2022Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	4583	usd
CY2021Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	269000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	550221	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	214783	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	125970	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	19947	usd
CY2022Q2	govx	Licensing Agreement Future Minimum Payments Receivable In Five Years LicensingAgreementFutureMinimumPaymentsReceivableInFiveYears	27500	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	789542	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	707159	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	574759	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156938	usd
CY2022Q2	us-gaap	Security Deposit SecurityDeposit	11010	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	11010	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	987508	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11010	usd
CY2022Q2	govx	Accrued License Fees Current AccruedLicenseFeesCurrent	3000000	usd
CY2021Q4	govx	Accrued License Fees Current AccruedLicenseFeesCurrent	3000000	usd
CY2022Q2	us-gaap	Other Liabilities OtherLiabilities	2000000	usd
CY2022Q2	govx	Licensing Agreement Future Minimum Payments Receivable Current LicensingAgreementFutureMinimumPaymentsReceivableCurrent	124200	usd
CY2022Q2	govx	Licensing Agreement Future Minimum Payments Receivable In Two Years LicensingAgreementFutureMinimumPaymentsReceivableInTwoYears	127500	usd
CY2022Q2	govx	Licensing Agreement Future Minimum Payments Receivable In Three Years LicensingAgreementFutureMinimumPaymentsReceivableInThreeYears	127500	usd
CY2022Q2	govx	Licensing Agreement Future Minimum Payments Receivable In Four Years LicensingAgreementFutureMinimumPaymentsReceivableInFourYears	27500	usd
CY2022Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	1082000	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	23405329
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1039762	usd
CY2022Q2	govx	Prepaid Expense Value Of Stock Issued For Services During Period PrepaidExpenseValueOfStockIssuedForServicesDuringPeriod	60000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	207178	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86763	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	412329	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	163553	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18967629
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3395635

Files In Submission

Name	View Source	Status
0001437749-22-018639-index-headers.html	Edgar Link	pending
0001437749-22-018639-index.html	Edgar Link	pending
0001437749-22-018639.txt	Edgar Link	pending
0001437749-22-018639-xbrl.zip	Edgar Link	pending
ex_401160.htm	Edgar Link	pending
ex_401161.htm	Edgar Link	pending
ex_401162.htm	Edgar Link	pending
ex_401163.htm	Edgar Link	pending
ex_401431.htm	Edgar Link	pending
ex_401432.htm	Edgar Link	pending
ex_401437.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
govx-20220630.xsd	Edgar Link	pending
govx-20220630_cal.xml	Edgar Link	unprocessable
govx-20220630_def.xml	Edgar Link	unprocessable
govx-20220630_lab.xml	Edgar Link	unprocessable
govx-20220630_pre.xml	Edgar Link	unprocessable
govx20220630_10q.htm	Edgar Link	pending
govx20220630_10q_htm.xml	Edgar Link	completed
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GOVX
GeoVax Labs, Inc. Stock $govx

2022 Q3 Form 10-Q Financial Statement

#000143774922018639 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GOVX GeoVax Labs, Inc. Stock $govx

2022 Q3 Form 10-Q Financial Statement

#000143774922018639 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GOVX
GeoVax Labs, Inc. Stock $govx